Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Management > Oasis in a Cash Flow Desert - Four Resources That Increase Small Business Capital Streams

Tags

  • really
  • percent
  • device
  • combination products
  • companies involved

  • Links

  • The Chemistry of Leather Care
  • Find the Perfect Picture Frame
  • Want to Publish a Book? 4 Things You Must Do First
  • Digg It - Oasis in a Cash Flow Desert - Four Resources That Increase Small Business Capital Streams

    For small business owners, an enthusiastic vision for smooth, steady growth can become nothing more than a mirage once company cash flow problems begin to heat up. Most will struggle with the timing of payment from clients or customers at s
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ome point, all while attempting to pay their own bills in a timely fashion. With all of the best laid plans for rapid flowing cash streams evaporating down to just a gurgle in the ditch, the potential risk of joining the ninety-percent of b
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    usinesses that fail within their first three years of operation becomes a very sobering possibility.

    Many of us would like to operate our companies the same way we do our personal lives. If we need a new lawn mower, we simply pull out the
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    trusty credit card, sign on the dotted line and put off worrying about it until next month. Meanwhile, we enjoy the benefits of the new equipment, at least for the time being, without it costing a dime. Though in this way we may seek a cert
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ain gratification from owning our possessions, it’s really just a trick we play on ourselves. The above “charge now, pay later” example doesn’t really convey any kind of real, initial ownership. Instead, it’s just a very common example of a
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    direct loan. The credit card company facilitates a credit arrangement between you and themselves, and the proceeds of this extension are directly used and repaid by you, the borrower.

    In business, however, whipping out the plastic to cove
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    r expenses is definitely not the best idea. Many have given in to this temptation, and are paying the heavy cost of damaged or ruined credit. And with that, their chances of digging out of the hole with other means of financing, which shoul
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    d have been sought in the first place, are slim to none.

    Thankfully, there are better, specially designed cash flow tools available for businesses that are beginning to feel the scorch of the capital income desert. Many business owners are
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    unaware of these tools. Others that are aware fail to take advantage of them. All of them would do well to at least consider the following:

    Purchase Order Financing - Simply put, this tool is a loan against the future income of the busine
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ss. It’s designed primarily to provide the cash needed to pay suppliers and sales-generating business expenses while patiently waiting for clients to pay their invoices. Similarly, purchase order funding is utilized for the completion of ex
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    isting orders by securing materials when working capital is running short. Once purchase order financing has been successfully utilized for some time, it usually becomes easier for the business to take advantage of more economical means of
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    credit.

    Equipment Leasing - With it’s one-hundred percent financing, preservation of credit lines, tax benefits and the ability to avoid obsolescence, equipment leasing is one of the sharpest and most efficient cash flow tools a business o
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    wner can utilize. Paying a premium in order to own equipment can be a huge waste of money. What companies profit from is the use of equipment, not the ownership. Leases can be extremely flexible to meet the custom needs of each business. Th
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    erefore, both small and medium-sized companies can greatly benefit from them.

    Accounts Receivable Financing - This tool provides a line of credit secured by the company’s accounts receivables. It is a strong method of financing for both sh
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ort-term working funds and the permanent working capital requirements of businesses that are growing. The paperwork is considerably less involved than in more traditional types of business loans. It is also especially helpful in providing f
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    inancing flexibility to firms that are growing rapidly.

    Factoring - This is the sale, at a discount, of a business’ accounts receivables. It is not based on the company’s ability to repay the money advanced. Instead, it based on their cust
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    omer’s ability to pay what is owed. Once the factoring facility purchases the accounts receivables, they assume the responsibility for collection. It is not a loan, so neither the time in business, nor the company's debt to equity ratio are
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    a consideration. A business has the freedom to sell only the AR that it chooses, and is not obligated to continue to do so. Factoring is an excellent source for additional working capital needed by both small and startup businesses.

    The d
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    escriptions above are general, and it’s important to understand that there is flexibility and variation within each lender program. In order to get educated on the details of these types of tools, and to find which of them might be benefici
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    al to your situation, talk to a professional loan broker or a commercial lender representative. He or she will explain the benefits of each, and help you decide which tools are right for keeping your business out of the cash flow wasteland.


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/23961/diggit-Oasis-in-a-Cash-Flow-Desert--Four-Resources-That-Increase-Small-Business-Capital-Streams.html">Oasis in a Cash Flow Desert - Four Resources That Increase Small Business Capital Streams</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/23961/diggit-Oasis-in-a-Cash-Flow-Desert--Four-Resources-That-Increase-Small-Business-Capital-Streams.html]Oasis in a Cash Flow Desert - Four Resources That Increase Small Business Capital Streams[/url]

    Related Articles:

    Ethics in Advertising

    Good Answers/Bad Answers: Tell Interviewers About Obstacles You've Overcome

    Baby Steps - The 10 Commandments As An Ethics Primer

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com